Toggle Nav
    cart icon My Cart
  • shopping list
  • region-flag Sony Biotechnology

FITC anti-human FOXP3

FITC anti-human FOXP3
Antibodies Single
Sony
206D
Flow Cytometry
Mouse IgG1, κ
Human
Full-length FOXP3 protein
2200530
$324.00
Add to Shopping List

Description

FOXP3 is a 50-55 kD transcription factor, also known as Forkhead box protein P3, Scurfin, JM2, or IPEX. It is proposed to be a master regulatory gene and more specific marker of T regulatory cells than most cell surface markers (such as CD4 and CD25). Transduced expression of FOXP3 in CD4+/CD25- cells has been shown to induce GITR, CD103, and CTLA4 and impart a T regulatory cell phenotype. FOXP3 is mutated in X-linked autoimmunity-allergic dysregulation syndrome (XLAAD or IPEX) in humans and in "scurfy" mice. Overexpression of FOXP3 has been shown to lead to a hypoactive immune state suggesting that this transcriptional factor is a central regulator of T cell activity. In human, unlike in mouse, two isoforms of FOXP3 have been reported: one (FOXP3) corresponding to the canonical full-length sequence; the other (FOXP3 δ2) lacking exon 2. The 206D antibody recognizes human FOXP3 epitope in the region of amino acids 105-235.

Formulation

Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and 0.2% (w/v) BSA (origin USA).

Recommended Usage

Each lot of this antibody is quality control tested by intracellular flow cytometry . Test size products are transitioning from 20 microL to 5 microL per test. Please check your vial or your CoA to find the suggested use of this reagent per million cells in 100 microL staining volume or per 100 microL of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

References

1. Roncador G, et al. 2005. Eur. J. Immunol. 35:1681.
2. Yang ZZ, et al. 2006. Blood 107:3639.
3. Liu W, et al. 2006. J. Exp. Med. 203:1701.PubMed
4. Bollyky PL, et al. 2007. J. Immunol. 179:744.
5. Bell MP, et al. 2007. J. Immunol. 179:1893.
7. Tran DQ, et al. 2007. Blood doi:10.1182/blood-2007-06-094656. PubMed
8. Gao Q,et al.2007.J Clin Oncol.25:2586.PubMed
9. Pillai V,et al. 2008. Blood 111:463.PubMed
10. Zheng Y, et al. 2008. J. Immunol. 181:1683. PubMed
11. Zonios DI, et al. 2008.Blood112:287. PubMed
12. Kavanagh B, et al. 2008. Blood. PubMed
13. Nevala WK, et al. 2009. Clin Cancer Res. 15:1931. PubMed
14. Grant J, et al. 2009. Cytometry B Clin Cytom. 76:69. PubMed
15. Nigam P, et al. 2010. J. Immunol. 184:1690. PubMed
16. Kmieciak M, et al. 2009. J. Transl. Med. 7:89. (ICFC) PubMed
17. Hartigan-O'Connor DJ,et al.2007.J Exp Med.204:2679. PubMed
18. Raghaven S, et al. 2009. Ann Rheum Dis. 68:1908. PubMed
19. Hodi FS, et al. 2014. Cancer Immunol Res. 2:632. PubMed
20. Sziros E, et al. 2015. Clin Cancer Res. 21:2840. PubMed